Viewing Study NCT03062969


Ignite Creation Date: 2025-12-24 @ 11:04 PM
Ignite Modification Date: 2026-01-05 @ 11:33 AM
Study NCT ID: NCT03062969
Status: COMPLETED
Last Update Posted: 2017-02-24
First Post: 2017-02-16
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: The Transition From Blastomere to Trophectoderm Biopsy: Comparing Two PGS Strategies
Sponsor: Fundacion Dexeus
Organization:

Study Overview

Official Title: The Transition From Blastomere to Trophectoderm Biopsy: Comparing Two PGS Strategies
Status: COMPLETED
Status Verified Date: 2017-02
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: Shortly after the implementation of Comprehensive Chromosome Screening (CCS) techniques for Preimplantation Genetic Screening (PGS) came the transition in biopsy timing. Trophectoderm biopsy is meant to overcome the limitations of cleavage stage biopsy and single cell analysis.
Detailed Description: The investigators have recently introduced this new approach and a frozen-thawed policy of euploid blastocysts is routinely performed.

This is a single centre retrospective study in patients undergoing a PGS cycle. The aim of the study is to assess the results obtained in a PGS programme after the implementation of a new biopsy timing and transfer policy. Results obtained in PGS cycles with blastocyst biopsy and frozen-thawed embryo transfer were analysed in comparison to cycles with cleavage stage biopsy and fresh blastocyst transfer.

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: